Teens: Cannabis Less Harmful Than Vapes, Alcohol
A study of more than 175,000 students found that teens consistently perceive cannabis as lower risk than nicotine products and alcohol, with perceived harm declining as students age.
A study of more than 175,000 students found that teens consistently perceive cannabis as lower risk than nicotine products and alcohol, with perceived harm declining as students age.
A study of more than 175,000 students found that teens consistently perceive cannabis as lower risk than nicotine products and alcohol, with perceived harm declining as students age.
Read MoreThe FDA authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application pathway.
Read More2019 was a turning point in youth vaping, as aggressive public health campaigns and extensive news coverage of e-cigarette or vaping product use-associated lung injury (EVALI) effectively curbed teen use.
Read MoreA study of over 92,000 incidents shows a 243% surge in e-cigarette exposures among toddlers, often involving direct inhalation from devices.
Read MoreA 2025 ban on disposable vapes in the United Kingdom may be pushing some users to smoke cigarettes instead, according to a youth survey.
Read MoreA Phase 1 clinical trial of Qnovia’s RespiRx handheld inhalable nicotine replacement therapy (NRT) revealed cigarette-comparable nicotine delivery with favorable safety profile.
Read MoreStatewide study finds students in funded schools were significantly less likely to smoke or vape than counterparts in schools without funding.
Read MoreAbstention from drug use remains at an historic high for teens, according to an annual survey of US adolescents.
Read MoreRutgers Health research confirms confusion about the different mechanisms that make nicotine and tobacco addictive.
Read MoreThe smoking cessation drug candidate cytisinicline significantly improved smoking quit rates compared to placebo in adults with and without COPD.
Read MoreNicotine pouch use has significantly increased, while vaping nicotine or cannabis were at all-time highs among American adults age 19-30 years old.
Read MoreThe first national estimate of daily nicotine pouch use in the US found that 2.5% of American adults use the product, and most users may be smokers who want to reduce or quit smoking.
Read MoreThe proliferation of nicotine pouch ingestions by children has prompted the FDA to call for child-resistant packaging for all products.
Read MoreYouth vaping is consistently linked to subsequent smoking, marijuana and alcohol use, and is associated with heightened risks of asthma, cough, injuries and mental ill health.
Read MoreA study evaluated whether vaporized nicotine products are more effective than nicotine replacement therapies for smoking cessation among people experiencing social disadvantage.
Read MoreThe European Society of Cardiology (ESC) has called for the European Union to apply higher excise taxes, advertising bans, and indoor-use restrictions to all nicotine products.
Read MoreNew data found an alarming 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023.
Read MoreAfter a few hundred puffs, some disposable vaping devices released higher amounts of metals and metalloids than older refillable e-cigarettes and traditional cigarettes.
Read MoreThe FDA will now review whether 20 Zyn nicotine pouch products “[put] you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis,” as the company claims.
Read MoreA joint operation from the US FDA and US CBP seized nearly two million units of unauthorized e-cigarette products in Chicago, with an estimated retail value of $33.8 million.
Read MoreCigarette smoking continues to decline across the United States, with the most dramatic declines coming in states with historically high smoking rates.
Read MoreExclusive e-cigarette use was not significantly associated with type 2 diabetes, heart failure or atherosclerotic cardiovascular disease, but it was significantly associated with COPD.
Read MoreAn app that uses carotid waveform measurements can provide insights into predicting the long-term risk of cardiovascular damage from e-cigarettes.
Read MoreThe US FDA authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application (PMTA) pathway.
Read More